EpiCept receives another Nasdaq notice

April

EpiCept Corp., an Eastview company that develops treatments for pain and cancer, has been notified by Nasdaq that it is out of compliance with listing requirements because its stock price closed below $1 a share for 30 straight days. The company now has 180 days, or until Oct. 13, to regain compliance with the rule by seeing that its stock closes at $1 a share or higher for at least 10 straight days.

This entry was posted on Monday, April 21st, 2008 at 11:04 am by Allan Drury.
You can follow any responses to this entry through the RSS 2.0 feed.
Print | Email

It is a condition of your use of the comment features associated with the blogs that you do not: Use the site to post or transmit any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information of any kind, including without limitation any transmissions constituting or encouraging conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any local, state, national or international law. You alone are responsible for the material you post or send. Refer to the Terms of Service.